Breaking News Instant updates and real-time market news.

BBY

Best Buy

$74.33

1.7 (2.34%)

, BURL

Burlington Stores

$208.91

2.9 (1.41%)

09:06
11/26/19
11/26
09:06
11/26/19
09:06

Fly Intel: Pre-market Movers

HIGHER: ChemoCentryx (CCXI), up 328% after announcing data from the phase 3 ADVOCATE trial of avacopan for the treatment of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis. This study met both of its primary endpoints, disease remission at 26 weeks and sustained remission at 52 weeks, as assessed by the Birmingham Vasculitis Activity Score... Purple Innovation (PRPL), up 1% after Raymond James analyst Bobby Griffin initiated coverage of the stock with an Outperform rating and $11 price target as he believes Purple's technology and manufacturing capabilities, combined with its omni-channel distribution, give it an opportunity to gain market share in the "highly competitive" mattress industry. UP AFTER EARNINGS: Best Buy (BBY), up 3%... Burlington Stores (BURL), up 3%... Dick's Sporting (DKS), up 10%. DOWN AFTER EARNINGS: Dollar Tree (DLTR), down 12%... Analog Devices (ADI), down 2%... Movado (MOV), down 19%... Bitauto (BITA), down 3%... Palo Alto Networks (PANW), down 8%. ALSO LOWER: Airgain (AIRG), down 11% after announcing that CFO Anil Doradla will be leaving the company to pursue other opportunities.

BBY

Best Buy

$74.33

1.7 (2.34%)

BURL

Burlington Stores

$208.91

2.9 (1.41%)

DKS

Dick's Sporting

$39.44

0.02 (0.05%)

DLTR

Dollar Tree

$112.41

3.37 (3.09%)

CCXI

ChemoCentryx

$8.06

0.13 (1.64%)

PRPL

Purple Innovation

$8.64

0.49 (6.01%)

ADI

Analog Devices

$113.02

2.37 (2.14%)

MOV

Movado

$25.18

1 (4.14%)

BITA

Bitauto

$15.34

0.25 (1.66%)

PANW

Palo Alto Networks

$250.21

3.29 (1.33%)

AIRG

Airgain

$9.97

0.145 (1.48%)

  • 26

    Nov

  • 26

    Nov

  • 26

    Nov

  • 26

    Nov

  • 26

    Nov

  • 26

    Nov

  • 26

    Nov

  • 02

    Dec

  • 03

    Dec

  • 05

    Dec

  • 09

    Dec

BBY Best Buy
$74.33

1.7 (2.34%)

11/11/19
CLVD
11/11/19
NO CHANGE
CLVD
Best Buy Q3 comps look set to slightly top consensus, says Cleveland Research
Cleveland Research analyst Scott Bender said his check indicate that Best Buy's Q3 comparable store sales are likely to grow toward the high end of guidance and slightly above the consensus forecast of 1.2%. He raised his EPS forecast slightly for Q3 based on based on the slight upside he sees to comps and easier margin comparisons, but said the holiday season outlook "seems mixed." Bender keeps a Neutral rating on Best Buy shares.
11/08/19
PIPR
11/08/19
NO CHANGE
Target $86
PIPR
Overweight
Best Buy 'increasingly attractive' as trade tensions ease, says Piper Jaffray
Piper Jaffray analyst Peter Keith says shares of Best Buy are "increasingly attractive" as U.S. and China trade tensions ease. The analyst refreshes Best Buy "as an intriguing investment idea," saying easing trade tensions helps to reduce an overhang on shares and that structural comp drivers are emerging. The stock's valuation is below historical averages, says Keith, who keeps an Overweight rating on Best Buy with an $86 price target.
11/07/19
NOMU
11/07/19
INITIATION
Target $73
NOMU
Neutral
Best Buy initiated with a Neutral at Nomura Instinet
Nomura Instinet analyst Michael Baker initiated coverage of Best Buy with a Neutral rating and $73 price target. The analyst says the company has been a "pioneer" in using an omnichannel strategy to compete with online retailers as it won back market share and expanded profitability over the past two years. Baker adds however that Best Buy is facing near-term headwinds and its 5-year plan is "backend loaded", stating that he would look for a better entry opportunity than at current levels.
10/21/19
LOOP
10/21/19
NO CHANGE
Target $90
LOOP
Buy
Aaron's price target raised to $90 from $73 at Loop Capital
Loop Capital analyst Anthony Chukumba raised his price target on Aaron's (AAN) to $90 and kept his Buy rating ahead of its Q3 results on November 4th, reflecting the company's recent announcement of rolled out Progressive offering at Lowe's (LOW) nationwide. The analyst expects investors to focus on the management's earnings call commentary regarding Progressive sales and the "invoice volume per active door" growth metric, along with any updates on its partnership with Best Buy (BBY). Chukumba is also raising his FY20 EPS view on Aaron's to $4.97 from $4.54.
BURL Burlington Stores
$208.91

2.9 (1.41%)

11/14/19
GUGG
11/14/19
NO CHANGE
Target $66
GUGG
Buy
Guggenheim raises price targets on off-price retailers TJX, Ross Stores
Guggenheim analyst Robert Drbul said the off-price sector remains one of his favorites in U.S. retail and he believes the environment will be supportive this holiday and in 2020 based on the inventory imbalance he sees in the marketplace today, which should create a product/buying environment that supports continued revenue gains. He predicts a return to postive double digit percentage earnings growth in 2020 and raised his price target on TJX (TJX) shares to $66 from $60 and his price target for Ross Stores (ROST) to $125 from $120. He has Buy ratings on both stocks. Elsewhere in the group, he keeps Neutral ratings on Burlington Stores (BURL), Nordstrom (JWN) and Macy's (M).
11/12/19
LEHM
11/12/19
INITIATION
Target $239
LEHM
Overweight
Burlington Stores initiated with an Overweight at Barclays
Barclays analyst Adrienne Yih initiated coverage of Burlington Stores with an Overweight rating and $239 price target. The analyst is positive on the strength of the company's off-price model as well as its flexibility, allowing it to be "both offensive when times are good and defensive when the economy is softer". Yih further cites Burlington Stores' recent addition of a new CEO and the recovery from product issues that impacted performance in 2018.
11/11/19
11/11/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Workiva (WK) initiated with a Neutral at Goldman Sachs. 2. Burlington Stores (BURL) and Ross Stores (ROST) were initiated with an Outperform at RBC Capital. 3. BellRing Brands (BRBR) initiated with an Overweight at JPMorgan, Morgan Stanley, and Barclays, an Outperform at Wells Fargo, Credit Suisse, and BMO Capital, a Buy at Goldman Sachs and Stifel, a Hold at SunTrust, and a Neutral at BofA/Merrill. 4. Anterix (ATEX) initiated with an Equal Weight at Morgan Stanley. 5. Gladstone (GOOD) initiated with a Buy at National Securities. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/11/19
RBCM
11/11/19
INITIATION
Target $230
RBCM
Outperform
Burlington Stores initiated with a Outperform at RBC Capital
RBC Capital analyst Kate Fitzsimons initiated coverage of Burlington Stores with an Outperform rating and $230 price target. The analyst notes that the company can continue to narrow its gross margins relative to its peers under the guidance of the new CEO, even as the company remains in the "middle innings" of its "off-price evolution". Fitzsimons adds that the premium valuation on Burlington Stores is warranted given its productivity and margin growth.
DKS Dick's Sporting
$39.44

0.02 (0.05%)

11/18/19
CLVD
11/18/19
NO CHANGE
CLVD
Dick's Sporting Q3 comps ahead of consensus, says Cleveland Research
Cleveland Research analyst Rusty Wilson said his checks checks indicate Q3 comps appear better versus Q2, ahead of consensus, with a holiday outlook that is positive based on assortment strategies. Wilson raised his Q3 comp estimate to up 4%, from 2.8%, versus consensus of 2.8%, and his Q3 earnings estimate to 41c from 38c, versus consensus of 37c. The analyst has a Neutral rating on Dick's shares.
11/19/19
SUSQ
11/19/19
NO CHANGE
Target $48
SUSQ
Positive
Dick's Sporting price target raised to $48 from $41 at Susquehanna
Susquehanna analyst Sam Poser raised his price target on Dick's Sporting to $48 from $41 ahead of Q3 results. the analyst raised his estimates as well to reflect support from major brands, an improving brand perception, and momentum from private labels, are driving an improvement in fundamentals. Poser reiterated his Positive rating on Dick's Sporting shares.
11/25/19
BOFA
11/25/19
UPGRADE
BOFA
Buy
Dick's Sporting upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill upgraded Dick's Sporting to Buy from Neutral.
11/25/19
BOFA
11/25/19
UPGRADE
Target $55
BOFA
Buy
Dick's Sporting upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Robert Ohmes upgraded Dick's Sporting (DKS) to Buy from Neutral with a $55 price target ahead of its Q3 results tomorrow, saying that at 11-times his expected FY21 earnings and given his upside same-store sales bias, the valuation on the stock is "compelling". The analyst believes that the company's digital and same-store sales momentum could accelerate further based on the success of its premium footwear selections as it receives "better lifestyle product assortment from Nike (NKE) and adidas (ADDYY), also noting that its apparel continues to be a strong category.
DLTR Dollar Tree
$112.41

3.37 (3.09%)

10/14/19
FBCO
10/14/19
NO CHANGE
Target $125
FBCO
Outperform
Dollar Tree price target raised to $125 from $110 at Credit Suisse
Credit Suisse analyst Judah Frommer raised his price target for Dollar Tree to $125 from $110 following the White House's announcement that it has reached the first phase of a trade deal with China that includes a delay in the tariffs that were set to take effect on October 15th; namely increasing tariffs from 25% to 30% on Lists 1-3. The analyst notes that over the past year, the company has been one of the most tariff-affected names within his coverage universe, from an operational perspective, given its limited price point at the Dollar Tree banner and its heavy reliance on direct imports from China. He reiterates an Outperform rating on the shares.
08/30/19
LOOP
08/30/19
NO CHANGE
Target $175
LOOP
Buy
Dollar General price target raised to $175 from $156 at Loop Capital
Loop Capital analyst Anthony Chukumba raised his price target on Dollar General (DG) to $175 after its Q2 results, saying the "beat and raise" quarter featured "robust" same store sales growth and operating expansion in the company's self-proclaimed "investment year". The analyst contends that the company's strategic initiatives are paying dividends sooner and at a higher than expected rate, which is a "start contrast" to the struggles at Dollar Tree (DLTR) to turn around its Family Dollar business.
10/22/19
WELS
10/22/19
NO CHANGE
Target $140
WELS
Outperform
Dollar Tree price target raised to $140 from $130 at Wells Fargo
Wells Fargo analyst Edward Kelly raised his price target for Dollar Tree to $140 from $130 on the growing potential for positive news on Family Dollar and Dollar Tree Plus in coming quarters. The analyst says he has noticed building optimism in management's tone and would not be surprised to hear more constructive commentary continue in coming quarters with the launch of higher price point discretionary items this holiday. Ultimately, the analyst sees expansion of the test or a full scale launch as a growing possibility sometime in 2020, which could be announced at a first half 2020 analyst day. He reiterates an Outperform rating on the shares.
09/11/19
JPMS
09/11/19
NO CHANGE
Target $125
JPMS
Overweight
Dollar Tree price target raised to $125 from $116 at JPMorgan
JPMorgan analyst Matthew Boss earlier today raised his price target for Dollar Tree to $125 from $116 after hosting meetings with management. The clear tone from management was "near-term confidence" in sales trends, Boss tells investors in a research note. The analyst keeps an Overweight rating on the shares.
CCXI ChemoCentryx
$8.06

0.13 (1.64%)

11/26/19
PIPR
11/26/19
NO CHANGE
Target $54
PIPR
Overweight
ChemoCentryx price target raised to $54 from $17 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff raised his price target for ChemoCentryx to $54 from $17 after the company announced positive Phase III Advocate data on avacopan in ANCA-associated vasculitis. The stock in premarket trading is up 312%, or $25.14, to $33.20. The trial met both primary endpoints of non-inferior Birmingham Vasculitis Activity Score remission compared to steroids at 26 and 52 weeks, Tenthoff tells investors in a research note. Based on these results, he believes avacopan could replace steroids in standard-of-care treatment of ANCA-associated vasculitis and potentially more broadly. He reiterates an Overweight rating on ChemoCentryx shares.
11/26/19
ADAM
11/26/19
NO CHANGE
Target $48
ADAM
Buy
ChemoCentryx price target raised to $48 from $16 at Canaccord
Canaccord analyst Michelle Gilson raised her price target on ChemoCentryx to $48 from $16 following its announcement of positive results from a Phase 2 ADVOCATE study that evaluated avocopan vs. glucocorticoid SOC in ANCA-associated vasculitis which hit both its primary endpoints. Gilson reiterated her Buy rating on ChemoCentryx shares.
11/26/19
HCWC
11/26/19
NO CHANGE
Target $40
HCWC
Buy
ChemoCentryx price target raised to $40 from $23 at H.C. Wainwright
H.C. Wainwright analyst Edward White raised his price target for ChemoCentryx to $40 from $23 after the company announced positive results from the Phase 3 Advocate study. The analyst increased his probability of success for avacopan to 70% from 30% and keeps a Buy rating on ChemoCentryx shares.
11/26/19
HCWC
11/26/19
NO CHANGE
Target $40
HCWC
Buy
ChemoCentryx price target raised to $40 from $23 at H.C. Wainwright
H.C. Wainwright analyst Edward White raised his price target for ChemoCentryx to $40 from $23 after the company announced positive results from the Phase 3 Advocate study. The analyst increased his probability of success for avacopan to 70% from 30% and keeps a Buy rating on ChemoCentryx shares.
PRPL Purple Innovation
$8.64

0.49 (6.01%)

11/26/19
RAJA
11/26/19
INITIATION
Target $11
RAJA
Outperform
Purple Innovation initiated with an Outperform at Raymond James
Raymond James initiated coverage of Purple Innovation with an Outperform rating and $11 price target.
11/26/19
RAJA
11/26/19
INITIATION
Target $11
RAJA
Outperform
Raymond James starts Purple Innovation at Outperform with $11 price target
Raymond James analyst Bobby Griffin initiated coverage of Purple Innovation with an Outperform rating and $11 price target as he believes Purple's technology and manufacturing capabilities, combined with its omni-channel distribution, give it an opportunity to gain market share in the "highly competitive" mattress industry. Overall industry drivers remain positive heading into 2020 despite late cycle economic fears and Purple has "a long runway for future opportunistic organic growth," Griffin added.
11/26/19
OPCO
11/26/19
INITIATION
Target $15
OPCO
Outperform
Purple Innovation initiated with an Outperform at Oppenheimer
Oppenheimer analyst Brian Nagel initiated coverage of Purple Innovation with an Outperform rating and $15 price target. The company represents a "digitally native, rapidly expanding" omni-channel manufacturer and seller of patent-protected polymer-based mattresses and cushioning products, Nagel tells investors in a research note. He believes a "significant, positive transformation" is now under way at the company and sees 80% upside in the shares.
11/25/19
KEYB
11/25/19
INITIATION
Target $12
KEYB
Overweight
Purple Innovation initiated with an Overweight at KeyBanc
KeyBanc analyst Bradley Thomas initiated coverage of Purple Innovation with an Overweight rating and $12 price target. The company is "attractively positioned to deliver solid" wholesale and direct-to-consumer growth, margin expansion, and continued innovation in the bedding industry, Thomas tells investors in a research note. The analyst believes Purple can continue to execute a turnaround story and drive operational and financial improvements.
ADI Analog Devices
$113.02

2.37 (2.14%)

10/30/19
RAJA
10/30/19
UPGRADE
Target $120
RAJA
Outperform
Analog Devices upgraded to Outperform from Market Perform at Raymond James
Raymond James analyst Christopher Caso upgraded Analog Devices to Outperform from Market Perform with a $120 price target.
10/30/19
RAJA
10/30/19
UPGRADE
Target $115
RAJA
Strong Buy
Microchip upgraded two notches to Strong Buy at Raymond James
Raymond James analyst Christopher Caso upgraded Microchip (MCHP) to Strong Buy from Market Perform with a $115 price target. In a research note to investors, Caso says that while he had hesitated to become more positive earlier in the year due to expectations for a 2H recovery which hasn't occurred, he says that based on industry checks over the last few months as well as peer reports, he feels convinced that current business conditions are getting neither better nor worse, and believes current revenue run rates are finally allowing inventory to drain from the channel and at customers. The analyst also upgraded Analog Devices (ADI).
10/30/19
10/30/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Biogen (BIIB) upgraded to Outperform from Market Perform at Bernstein with analyst Aaron Gal saying that the controversy is solidly around aducanumab. 2. Nu Skin (NUS) upgraded to Hold from Sell at Stifel with analyst Mark Astrachan saying while he thinks trends in China, which makes up 33% of sales, will likely remain negative for the foreseeable future, he now thinks they are unlikely to worsen. 3. Microchip (MCHP) upgraded two notches to Strong Buy from Market Perform at Raymond James while Analog Devices (ADI) was upgraded to Outperform from Market Perform. 4. National Oilwell (NOV) upgraded to Buy from Neutral at Goldman Sachs with analyst Angie Sedita citing the company's revenue growth and cost cutting. 5. AMD (AMD) upgraded to Buy from Hold at Loop Capital and CFRA. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/30/19
RAJA
10/30/19
UPGRADE
Target $120
RAJA
Outperform
Analog Devices upgraded to Outperform from Market Perform at Raymond James
Raymond James analyst Christopher Caso upgraded Analog Devices (ADI) to Outperform from Market Perform with a $120 price target. In a research note to investors, Caso says that while he had hesitated to become more positive earlier in the year due to expectations for a 2H recovery which hasn't occurred, he says that based on industry checks over the last few months as well as peer reports, he feels convinced that current business conditions are getting neither better nor worse, and believes current revenue run rates are finally allowing inventory to drain from the channel and at customers. The analyst also upgraded Microchip (MCHP).
MOV Movado
$25.18

1 (4.14%)

08/29/19
COWN
08/29/19
DOWNGRADE
Target $22
COWN
Market Perform
Movado downgraded to Market Perform at Cowen
As reported previously, Cowen analyst Oliver Chen downgraded Movado to Market Perform from Outperform. The analyst moved tot he sidelines given lower visibility into future growth, and a deceleration of revenue growth combined with expense de-leverage. He said key headwinds include, category pressures, US and International Wholesale challenges, consumer confidence risk, and tariffs. Chen lowered his price target to $22 from $40 on Movado shares.
08/29/19
COWN
08/29/19
DOWNGRADE
COWN
Market Perform
Movado downgraded to Market Perform from Outperform at Cowen
Cowen analyst Oliver Chen downgraded Movado to Market Perform from Outperform.
11/29/18
IBBA
11/29/18
UPGRADE
IBBA
Outperform
America Movil upgraded to Outperform from Market Perform at Itau BBA
08/29/19
08/29/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Box (BOX) downgraded to Neutral from Outperform at First Analysis and to Hold from Buy at Craig-Hallum. 2. G-III Apparel (GIII) downgraded to Hold from Buy at Stifel with analyst Jim Duffy saying his more cautious outlook reflects "shocks" to his fiscal 2021 earnings estimates from tariffs on China manufactured goods sold in the U.S. 3. Tapestry (TPR) and Movado (MOV) downgraded to Market Perform from Outperform at Cowen. 4. Solid Biosciences (SLDB) downgraded to Sell from Neutral at Citi with analyst Joel Beatty saying the stock has nearly doubled over the last month without anything fundamental changing, which has opened up a sell opportunity. 5. Casey's General Stores (CASY) downgraded to Underperform from Sector Perform at RBC Capital with analyst Irene Nattel citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
BITA Bitauto
$15.34

0.25 (1.66%)

06/28/19
JPMS
06/28/19
DOWNGRADE
Target $3.5
JPMS
Underweight
JPMorgan cautious on China ad recovery, downgrades Sogou, cuts Baidu target
JPMorgan analyst Alex Yao last night downgraded Sogou (SOGO) to Underweight from Neutral and lowered his price target for the shares to $3.50 from $5.50. The analyst says he found no evidence to support the "widely adopted optimism" on an advertising growth recovery in the second half of 2019 for the China Internet sector. As a result, he's cautious on names with high exposure to online ads, or Baidu (BIDU), Weibo (WB), Sogou, Focus Media, Autohome (ATHM), and Bitauto (BITA). Yao downgraded both Sogou and Focus Media to Underweight and lowered his price target for Neutral-rated Baidu to $120 from $150.
11/29/18
FBCO
11/29/18
DOWNGRADE
FBCO
Neutral
Bitauto downgraded to Neutral from Outperform at Credit Suisse
PANW Palo Alto Networks
$250.21

3.29 (1.33%)

11/26/19
WEDB
11/26/19
NO CHANGE
Target $275
WEDB
Outperform
Wedbush still 'firmly bullish' on Palo Alto Networks despite product miss
Wedbush analyst Daniel Ives says Palo Alto Networks reported "mixed" October quarter results last night as the company beat the Street's sales and billings estimates while delivering "weak" product and cash flow numbers. The analyst, however, is "not overly alarmed" by the product miss and remains "firmly bullish" on the company and risk/reward for the next year. He keeps an Outperform rating on Palo Alto Networks with a $275 price target.
11/26/19
LEHM
11/26/19
NO CHANGE
Target $260
LEHM
Overweight
Palo Alto Networks price target lowered to $260 from $264 at Barclays
Barclays analyst Saket Kalia lowered his price target for Palo Alto Networks to $260 from $264 while keeping an Overweight rating on the shares following last night's results. Billings is the most important metric, but product still matters, "which is why this rally will get cut short," Kalia tells investors in a post-earnings research note. Management attributed the product miss to execution related to changing sales incentives, adds the analyst.
11/26/19
SBSH
11/26/19
NO CHANGE
Target $283
SBSH
Buy
Palo Alto Networks price target raised to $283 from $247 at Citi
Citi analyst Walter Pritchard raised his price target for Palo Alto Networks to $283 from $247 saying that despite the $25M product miss in fiscal Q1, cloud subscriptions more than made up for the difference on billings. The analyst believes the company's profitability "holds while considerable investments continue." The market will soon place a premium on security companies that are "on-sides" with cloud trend, where Palo Alto is leading, Pritchard tells investors in a post-earnings research note. He keeps a Buy rating on the shares.
11/26/19
OPCO
11/26/19
NO CHANGE
Target $275
OPCO
Outperform
Palo Alto Networks price target lowered to $275 from $285 at Oppenheimer
Oppenheimer analyst Shaul Eyal lowered his price target for Palo Alto Networks to $275 from $285 following the company's "mixed" Q1 results. The analyst, however, believes the company's long-term outlook is intact and he maintains an Outperform rating on the name.
AIRG Airgain
$9.97

0.145 (1.48%)

05/06/19
RILY
05/06/19
NO CHANGE
Target $22
RILY
Buy
Airgain price target raised to $22 from $19 at B. Riley FBR
B. Riley FBR analyst Craig Ellis raised his price target for Airgain to $22 from $19 and keeps a Buy rating on the shares. The analyst sees the company gaining further traction through 2019.
11/26/19
WBLR
11/26/19
DOWNGRADE
WBLR
Market Perform
Airgain downgraded to Market Perform from Outperform at William Blair
William Blair analyst Alessandra Vecchi downgraded Airgain to Market Perform from Outperform after the company's Chief Financial Officer Anil Doradla said he will be leaving the company. While Airgain has made progress on its sales and marketing realignment and gross margin efficiency efforts, the lack of consistency in management over the last two years will serve as an overhang to shares, Vecchi tells investors in a research note.
11/26/19
WBLR
11/26/19
DOWNGRADE
WBLR
Market Perform
Airgain downgraded to Market Perform from Outperform at William Blair
William Blair analyst Alessandra Vecchi downgraded Airgain to Market Perform from Outperform after the company's Chief Financial Officer Anil Doradla said he will be leaving the company. While Airgain has made progress on its sales and marketing realignment and gross margin efficiency efforts, the lack of consistency in management over the last two years will serve as an overhang to shares, Vecchi tells investors in a research note.
11/26/19
RILY
11/26/19
DOWNGRADE
Target $11.5
RILY
Neutral
Airgain downgraded to Neutral from Buy at B. Riley FBR
B. Riley FBR analyst Craig Ellis downgraded Airgain to Neutral from Buy with a price target of $11.50, down from $18. The analyst cites the company's CFO transition for the target reduction and downgrade.

TODAY'S FREE FLY STORIES

EVH

Evolent Health

$8.60

-0.39 (-4.34%)

, ANTM

Anthem

$280.75

-2.84 (-1.00%)

13:48
12/11/19
12/11
13:48
12/11/19
13:48
Periodicals
Outgoing Kentucky administration upholds 'snub' of Evolent partner, LCJ says »

The finance secretary of…

EVH

Evolent Health

$8.60

-0.39 (-4.34%)

ANTM

Anthem

$280.75

-2.84 (-1.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAAS

Pan American Silver

$20.30

0.53 (2.68%)

13:45
12/11/19
12/11
13:45
12/11/19
13:45
Options
Pan American Silver call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:45
12/11/19
12/11
13:45
12/11/19
13:45
General news
Treasury Budget to be reported at 14:00 »

November Treasury Budget…

13:45
12/11/19
12/11
13:45
12/11/19
13:45
General news
FOMC Meeting Announcement Federal Funds Rate to be reported at 14:00 »

FOMC Meeting Announcement…

SBPH

Spring Bank Pharmaceuticals

$3.20

-0.25 (-7.25%)

13:41
12/11/19
12/11
13:41
12/11/19
13:41
Recommendations
Spring Bank Pharmaceuticals analyst commentary  »

Spring Bank to add CASOs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTL

CenturyLink

$13.99

-0.155 (-1.10%)

13:25
12/11/19
12/11
13:25
12/11/19
13:25
Options
CenturyLink call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CFX

Colfax

$34.68

0.39 (1.14%)

13:25
12/11/19
12/11
13:25
12/11/19
13:25
Conference/Events
Cowen industrial innovation analyst to hold an analyst/industry conference call »

Industrial Innovation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 18

    Dec

BIIB

Biogen

$293.60

-3.45 (-1.16%)

13:25
12/11/19
12/11
13:25
12/11/19
13:25
Conference/Events
SVB Leerink biotech analyst to hold analyst/industry conference call »

Biotech Analysts, along…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

XLNX

Xilinx

$93.24

1.99 (2.18%)

13:25
12/11/19
12/11
13:25
12/11/19
13:25
Conference/Events
Xilinx participates in a conference call with Benchmark »

Semiconductor Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 06

    Jan

  • 28

    Jan

DISCA

Discovery

$32.21

-0.03 (-0.09%)

, DISCK

Discovery Inc.

$29.98

-0.005 (-0.02%)

13:21
12/11/19
12/11
13:21
12/11/19
13:21
Periodicals
Bruin Sports explores sale of streaming provider Deltatre, Bloomberg says »

Bruin Sports Capital is…

DISCA

Discovery

$32.21

-0.03 (-0.09%)

DISCK

Discovery Inc.

$29.98

-0.005 (-0.02%)

DIS

Disney

$146.88

0.76 (0.52%)

AMZN

Amazon.com

$1,737.40

-1.75 (-0.10%)

CMCSA

Comcast

$42.17

-0.6 (-1.40%)

CMCSK

Comcast

$0.00

(0.00%)

TWTR

Twitter

$30.17

0.32 (1.07%)

NFLX

Netflix

$297.28

4.07 (1.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

LQDT

Liquidity Services

$6.15

-0.27 (-4.21%)

13:21
12/11/19
12/11
13:21
12/11/19
13:21
Recommendations
Liquidity Services analyst commentary  »

Liquidity Services on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
12/11/19
12/11
13:17
12/11/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
12/11/19
12/11
13:16
12/11/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLW

Corning

$28.28

0.28 (1.00%)

13:15
12/11/19
12/11
13:15
12/11/19
13:15
Options
Corning put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

PNRG

PrimeEnergy

$153.00

-2 (-1.29%)

13:15
12/11/19
12/11
13:15
12/11/19
13:15
Hot Stocks
PrimeEnergy director Clint Hurt sells over $1.1M in company shares »

PrimeEnergy director…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMBA

Ambarella

$54.84

2.33 (4.44%)

13:05
12/11/19
12/11
13:05
12/11/19
13:05
Options
Ambarella call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

FB

Facebook

$201.00

0.1 (0.05%)

, ICE

IntercontinentalExchange

$92.63

0.31 (0.34%)

12:56
12/11/19
12/11
12:56
12/11/19
12:56
Periodicals
Nasdaq on track to beat NYSE in IPOs for first time since 2012, WSJ says »

Companies are on pace to…

FB

Facebook

$201.00

0.1 (0.05%)

ICE

IntercontinentalExchange

$92.63

0.31 (0.34%)

NDAQ

Nasdaq

$104.36

-0.26 (-0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 29

    Jan

  • 06

    Feb

12:55
12/11/19
12/11
12:55
12/11/19
12:55
Conference/Events
UBS retail analysts to hold an analyst/industry conference call »

Retail Analysts…

SGEN

Seattle Genetics

$111.78

-2.19 (-1.92%)

12:53
12/11/19
12/11
12:53
12/11/19
12:53
Recommendations
Seattle Genetics analyst commentary  »

Seattle Genetics data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Mar

TWTR

Twitter

$30.16

0.31 (1.04%)

, SQ

Square

$65.52

-0.3 (-0.46%)

12:48
12/11/19
12/11
12:48
12/11/19
12:48
On The Fly
#SocialStocks: YouTube updates harassment policy, Snapchat 'deepfake' GIFs »

Welcome to…

TWTR

Twitter

$30.16

0.31 (1.04%)

SQ

Square

$65.52

-0.3 (-0.46%)

FB

Facebook

$201.03

0.13 (0.06%)

AMZN

Amazon.com

$1,738.68

-0.47 (-0.03%)

SNAP

Snap

$14.15

0.065 (0.46%)

GOOGL

Alphabet Class A

$1,342.74

-0.3 (-0.02%)

GOOG

Alphabet

$1,344.23

-0.27 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 26

    Feb

CIEN

Ciena

$35.15

0.45 (1.30%)

, LOVE

Lovesac

$14.52

0.08 (0.55%)

12:48
12/11/19
12/11
12:48
12/11/19
12:48
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

CIEN

Ciena

$35.15

0.45 (1.30%)

LOVE

Lovesac

$14.52

0.08 (0.55%)

VERU

Veru

$2.27

-0.03 (-1.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

  • 17

    Dec

  • 19

    Dec

LULU

Lululemon

$232.23

2.67 (1.16%)

, NDSN

Nordson

$165.56

-0.19 (-0.11%)

12:48
12/11/19
12/11
12:48
12/11/19
12:48
Earnings
Notable companies reporting after market close »

Notable companies…

LULU

Lululemon

$232.23

2.67 (1.16%)

NDSN

Nordson

$165.56

-0.19 (-0.11%)

OXM

Oxford Industries

$74.50

-1.46 (-1.92%)

MESA

Mesa Air

$9.04

-0.04 (-0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 11

    Dec

  • 12

    Dec

CSCO

Cisco

$44.29

0.18 (0.41%)

, CMCSA

Comcast

$42.04

-0.73 (-1.71%)

12:45
12/11/19
12/11
12:45
12/11/19
12:45
Hot Stocks
Cisco announces 'Internet for the Future' strategy »

Cisco (CSCO) unveiled…

CSCO

Cisco

$44.29

0.18 (0.41%)

CMCSA

Comcast

$42.04

-0.73 (-1.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

  • 08

    Jan

  • 12

    Feb

ADI

Analog Devices

$115.90

1.48 (1.29%)

12:45
12/11/19
12/11
12:45
12/11/19
12:45
Options
Analog Devices call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 18

    Dec

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$313.73

0.18 (0.06%)

12:45
12/11/19
12/11
12:45
12/11/19
12:45
Hot Stocks
Gundlach says in next recession, U.S. will be worst stock market in world »

DoubleLine CEO Jeffrey…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$313.73

0.18 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.